|
Website:
http://www.daidan.co.jp
Phone: +81 6 6441 8231 |
Address:
9-25 Edobori 1-Chome
Nishi-Ku, Osaka 550-8520, Osaka 550-8520 |
Company Description
Dai-Dan Company Limited. The Group's principal activity is to provide electrical engineering services such as installation of power incoming systems, transforming systems, generator systems, central monitoring systems, main power distribution systems, power supply and control systems and lighting systems. The Group is also involved in the services for air conditioning systems, smoke exhaust systems, integrated automatic control systems and installation for waste and drainage systems and fire hydrants. Provides electrical engineering services such as installation of power incoming systems, transforming systems etc
Key People
| Chairman | Setsu Sugaya(Rep) |
| President | Hisakazu Ando(Rep) |
Related Business Topics
Breaking News
CNN - 15 hours ago
NEW YORK (Fortune) -- Dear Annie: Late last year, the software company where I worked as a full-time webmaster had to lay people off, but they kept some of us on as independent contractors. My boss offered me a deal where I would be doing the exact same ...
ZDNet UK - November 26, 2009 1:52 AM
:44 GMT Mozilla Messaging has issued the first release candidate of Thunderbird 3, the software it hopes will significantly improve how people read, write, catalogue and search their email. Mozilla on Tuesday for , and , several days later than predicted ...
New York Times - November 25, 2009 10:13 AM
I™m an American currently living in Britain (and covered by the National Health Service). and about to go on a round-the-world backpacking trip for the next 6 to 12 months. Travel health insurance is pretty expensive and seems to only really cover ...
Reuters - November 25, 2009 7:02 AM
CAMBRIDGE, Mass.--(Business Wire)-- Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Piper ...
Forbes.com - November 25, 2009 6:10 AM
BusinessWire - Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Piper Jaffray 21st Annual ...
